Peak XV Partners nets over ₹1,200 crore after exiting stake in Porter, clocking 11-fold return
Mumbai: Peak XV Partners netted over ₹1,200 crore after exiting its investment in logistics company Porter's latest funding round, a person familiar with the matter said. The profit was an over 11-fold return on investments of ₹116 crore across multiple rounds over the past decade.
'The company has grown tremendously since our Series A investment in 2015 to now become worth over a billion dollars. After a decade-long partnership with the team, we have exited our investment and express our heartfelt gratitude to the founding team, Uttam Digga, Pranav Goel, and Vikas Choudhary, for being wonderful partners," a spokesperson for Peak XV said, without disclosing the exit value.
Porter declined to comment on the stake sale.
The Bengaluru-based company joins a growing list of unlisted firms including Rebel Foods, Healthkart, Finova, K12 Techno and Cloudnine Hospitals where Peak has sold partial or full stakes.
The venture capital firm has also sold stakes in companies that were headed for public listing or has pared stakes in already listed firms such as Ixigo, Awfis, Go Digit General Insurance, Blackbuck, Zomato, Mamaearth, Truecaller, Indigo Paints, Five Star Business Finance and MobiKwik.
Peak has generated about $3.6 billion in cash exits over the past five years and over 30 portfolio companies have gone public. In 2024 alone, it recorded exits to the tune of $1.5 billion, exceeding the amount it invested in the timeframe, the person added.
Also Read | Wellington Management may lead Porter's $100 million round in logistics push
Porter's round, which was led by Kedaara Capital and Wellington Management and valued the company at $1.2 billion, had a mix of primary and secondary stake sales, with others such as Kae Capital also exiting.
Porter said last week it plans to use the funds raised to expand operations, build teams, and develop technology and operational excellence while continuing to set up a greener logistics network aligned with India's decarbonisation efforts.
Peak plans
Meanwhile, Peak is in early talks to raise up to $1.4 billion by the end of the current financial year for its first India-SEA (Southeast Asia) fund since the split with parent Sequoia Capital. The VC firm expects at least two dozen companies to tap the public market in the next 12-18 months, according to the person.
Also Read | Mint Explainer: Can Uber shake up the market Porter dominates?
The investment firm expects to back more funds launched by former company executives. Investing in funds is a tried and tested way for new VC and private equity firms to enter a new market. When global investors first started investing in India, they made several investments in Indian fund managers to understand the market before they started making direct investments.
Partners at Peak have been investing since 2006 and had access to the US market when they were part of Sequoia Capital. However, this access ended in June 2023, when Sequoia split into three globally. The India and Southeast Asia team became Peak XV Partners. In the past year, the venture capital firm has invested in a handful of seed and early-stage US funds, varying in size from $1 million to $10 million.
For the past two years, Peak XV has been building its US presence to regain the access it had as part of Sequoia. One key reason is to help its portfolio companies that are based in the US or have links to the US market.
Also Read | Choppy markets take toll on pre-IPO deal talks
It has a portfolio of more than 400 companies across financial services, software and artificial intelligence (AI), and consumer internet, and across stages—seed, venture and growth. Almost 150 companies have ties to the US market—either for market access or founded by Indian origin people incorporated in the US.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
38 minutes ago
- Time of India
Batteries, EVs under threat? India fires on all cylinders for rare earths amid China's tightening grip
As China tightens its stranglehold on the global supply of rare earth elements , India is shifting gears — fast. From forging new partnerships in Central Asia to finalising an ambitious incentive scheme for mineral recycling , India is pushing ahead to secure its place in the global race for critical minerals . At the recently held India-Central Asia Dialogue in New Delhi, India and five Central Asian nations expressed mutual interest in jointly exploring rare earths and other critical minerals. In a joint statement, they called for an early meeting of the India-Central Asia Rare Earth Forum, signalling growing geopolitical urgency to diversify away from China's near-monopoly. China's chokehold spurs urgency The backdrop to these moves is no coincidence. Over the past year, China has weaponised its control over rare earths, placing several critical minerals and magnets under strict export licence regimes. These are the very components vital for electric vehicles , wind turbines, semiconductors, and even military-grade systems. Beijing's message is clear: if the West can play export control hardball, China has its own scalpel and it's now using it with surgical precision. While the US, Europe, and Japan scramble to find alternative supply lines, India sees an opening — and it's moving to capitalise. From mission to momentum Under the Rs 34,300 crore National Critical Mineral Mission (NCMM), India aims to become self-reliant in sourcing and processing critical minerals like lithium, cobalt, nickel, and rare earth elements. Joint Secretary in the Mines Ministry, Dinesh Mahur, announced that an incentive scheme for recycling these minerals is in its final stages. The Union Budget has already earmarked Rs 1,500 crore specifically for this effort. Public Sector Enterprises are expected to contribute Rs 18,000 crore to the mission. With a sharp focus on domestic exploration, overseas block acquisition, and technological R&D, the NCMM is India's boldest bet yet to insulate its industries from global supply shocks. Auto industry feels the heat The urgency is not just strategic — it's also economic. Rare earth shortages are already casting a shadow over India's auto sector, especially electric vehicles (EVs), which depend on permanent magnets for motors. Bajaj Auto has warned that its e-scooter production could be impacted from July if Chinese export delays continue. TVS Motor has echoed similar concerns. According to the Federation of Automobile Dealers Associations (FADA), only a third of its members expect sales growth in June. The rare earth crunch, combined with high inventories and tight financing, has pushed automakers to brace for a cautious month — especially as the EV rollout faces headwinds. China's long game, India's fast track What China is doing today has been decades in the making. The world first saw signs of Beijing's ambitions in 2010 when it temporarily banned rare earth exports to Japan over a territorial spat. By 2020, China had passed its own Export Control Law, giving it sweeping powers to curb exports of materials deemed vital to national security. The law was broad enough to include critical minerals, tech, and even data. Now, with the US-China trade war escalating, rare earths have become Beijing's leverage. Export licenses have slowed, production lines in Europe have paused, and Washington is on edge. China's near-monopoly on processing and refining rare earths — not just mining them — means that even if other countries dig up the ores, they'll still need China to process them. Which is why India's current push isn't just policy — it's necessity. The Road Ahead While China refines 90% of the world's rare earths, India is still building capacity. But the groundwork is being laid — with diplomatic ties, budgetary commitments, and strategic focus. The success of the NCMM could determine whether India emerges as a resilient alternative or remains vulnerable to future supply shocks. With global demand for EVs, semiconductors, and green energy tech rising, the stakes couldn't be higher. In this global battle for minerals that power the future, India is no longer on the sidelines. It's suiting up — and firing on all cylinders.
Time of India
38 minutes ago
- Time of India
ETtech Deals Digest: Startups raise $142.7 million this week, up 8.5% on-year
Live Events Startups in India raised $142.7 million in funding across 14 rounds between May 31 and June 6, up 8.5% over the same week last the same period last year, startups had raised $131.5 million across 64 rounds. Funding fell marginally over the last week, where $147.7 million was raised in 16 activity was high among late and early-stage startups, lagging in the seed Singapore-based wealth management platform raised $53 million in a fresh funding round, led by two UK-based family offices. In August 2024, the company had raised $27 million as part of the same round, and this extension takes the total funds raised in the round to $80 (B2B) ecommerce platform Udaan closed a $114 million funding round led by existing investors M&G Prudential (UK) and Lightspeed Venture Partners. The round, executed at a flat valuation of $1.8 billion, includes the previously disclosed $75 million infusion from the two investors, which founder and CEO Vaibhav Gupta had announced during a townhall earlier this wealthtech startup, which provides digital fixed-return investment products, raised $20 million (Rs 173 crore) in a funding round led by Infosys cofounder Nandan Nilekani's Fundamentum digital lending platform Loantap announced raising $6.2 million in fresh equity funding led by July Ventures. Existing investors 3one4 Capital, Avaana Capital, Kae Capital and the Swapurna Family Office also participated in the financing startup GyanDhan has raised Rs 50 crore in a funding round from edtech firm Classplus and venture capital firm Pravega Ventures. The funds will be used for scaling operations, strengthening its consultant partnership network, expanding the team, and investing in furniture and home goods company Pepperfry raised Rs 43.3 crore from existing investors Norwest Venture Partners, Goldman Sachs, General Electric Pension Trust, Growth Equity Opportunity Fund, and Panthera Growth Partners, among a climate-tech-focussed asset financing and management platform, raised $3.5 million in a funding round led by the clean mobility-focused Micelio Technology Fund.
Indian Express
38 minutes ago
- Indian Express
Road show on investment opportunities in UP held in Ahmedabad: UPSIDA
The Uttar Pradesh State Industrial Development Authority (UPSIDA) organised a roadshow on Friday in Ahmedabad on the theme 'Investment Opportunities in Uttar Pradesh's Pharmaceutical Sector.' The primary objective of this event was to apprise investors of the vast opportunities available in Uttar Pradesh's growing pharmaceutical industry and to invite them to explore business prospects within the state, a statement said. The event saw participation from key stakeholders in the pharma sector, including industry leaders, investors and policymakers. UPSIDA is developing a Bulk Drug Pharma Park spread across 1,472.33 acres in the Lalitpur district, with a proposed investment of approximately Rs 250 crore. This Pharma Park is estimated to attract an investment of approximately Rs 12000 crore. The event commenced with the registration process, followed by a welcome address by Swapnil Shah, Convenor of the CII Gujarat Pharma & Healthcare Panel and CEO & MD of Senores Pharmaceuticals Ltd. A short film showcasing Uttar Pradesh's industrial growth, investor-friendly policies, and robust infrastructure was presented to give investors a comprehensive overview of the state's potential, said the statement. In his address, UPSIDA CEO Mayur Maheshwari emphasised the rapid development of pharma parks in Uttar Pradesh. He elaborated on the investment process, land allotment, and the range of facilities available to industries, extending a direct invitation to Gujarat-based entrepreneurs to invest in the state. During the investment session held in Ahmedabad, UPSIDA signed several Memorandums of Understanding (MoUs) with leading pharmaceutical and healthcare companies.
